evidoria

← Back to browse

Good practice Imported

Yissum — Hebrew University of Jerusalem's Technology Transfer Company

Israel · Jerusalem · See the Israel profile · See the Jerusalem profile

Evidence: Descriptive / self-reported Top 65% 62/100 · Ask Evidence Copilot about this practice

Founded in 1964, Yissum — Hebrew University of Jerusalem's tech-transfer company — has registered over 10,500 patents and licensed 1,000+ technologies. Independent press credits its spin-offs, including Mobileye, with roughly $2bn in annual sales.

10,500+ patents
Patents registered (self-reported) (since 1964)
~2,500 inventions
Inventions covered (since 1964)
1,000+ licences
Technologies licensed (since 1964)
~100 companies
Active portfolio companies (current)
~2 USD billion
Combined annual sales of Hebrew University-derived products (annual)

Details

Maturity
Established
Promoter
Yissum Research Development Company of the Hebrew University of Jerusalem
Period
1964–present
Keywords
university technology transfer, licensing, spin-offs

Context

Yissum, founded in 1964 and describing itself as the world's third university technology-transfer company, manages intellectual property arising from Hebrew University of Jerusalem research, negotiating licences and spinning out companies, with international liaison offices in Chicago, Asunción and Shenzhen to speed cross-border commercialisation.

Results

Yissum's own materials state it has registered more than 10,500 patents covering about 2,500 inventions, licensed over 1,000 technologies, and helped build roughly 100 active portfolio companies. Independent coverage from the Times of Israel and Israel21c corroborates its role as a leading Israeli technology-transfer body and credits Hebrew University-derived products — including Novartis's Exelon, Johnson & Johnson's Doxil, and the computer-vision spin-off Mobileye — with generating on the order of $2 billion in combined annual sales.

Conclusions

A caution worth flagging: reported patent, licensing and company-count figures vary meaningfully between Yissum's own materials and third-party profiles from different years (for example, 10,500 vs. 11,500 patents, and 100 vs. 245 spin-off companies across sources).

Implementation
Indicative cost
Medium (€50k–€500k)
Time to results
Long (> 3 years) — Founded 1964; operating continuously for 61 years as of the source description.

Conditions for success

  • International liaison offices (Chicago, Asunción, Shenzhen) to speed cross-border commercialisation
  • Six decades of continuous operation building an internal patent and licensing pipeline

Common failure modes

  • Inconsistent self-reported metrics across years and sources (e.g. 10,500 vs 11,500 patents; 100 vs 245 spin-off companies) reduce confidence in headline figures

Commonly funded by

National / regional programmes

Indicative funding routes for practices of this type — always check each programme's current calls and eligibility rules.

Do you run this practice? Claim it — verified implementers get a public contact pathway and can propose corrections.

Data sources

Where this practice's information was retrieved from, and when.

Similar practices you may find useful